Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

23 results
Display

Long-Lasting Antiandrogen Withdrawal Syndrome in Castration-Resistant Prostate Cancer: Three Cases With Complete Response

Kim SJ, Ryu JH, Kim YB, Jung TY

This is a case report of 3 patients who had a dramatic and long-term complete response after antiandrogen withdrawal. All 3 patients were diagnosed with advanced or metastatic prostate cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Concepts in Androgen Deprivation Therapy

Hong JH, Choi HY

The hormonal sensitivity of prostate cancer has been exploited clinically since Huggins and Hodges established the suppressive effects of castration on prostate cancer. Despite over sixty years of research into...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of Androgen Receptor in Prostate Cancer: A Review

Fujita K, Nonomura N

Androgen receptor (AR) is a steroid receptor transcriptional factor for testosterone and dihydrotestosterone consisting of four main domains, the N-terminal domain, DNA-binding domain, hinge region, and ligand-binding domain. AR plays...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug Therapy: What It Means to the Dermatologist and to the Patient

Maddin S

  • KMID: 2146618
  • Korean J Dermatol.
  • 1986 Apr;24(2):173-180.
The current treatment of acne vulgaris utilizing both topical and systemic agents i eviewed. New therapeutic agents such as the retinoids and their newer analogus etretin and RO-15-0778, antiandrogens cyproterone...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Alternative Antiandrogen Therapy for Prostate Cancer That Relapsed after Initial Maximum Androgen Blockade

Choi JI, Kim YB, Yang SO, Lee JK, Jung TY

  • KMID: 2315439
  • Korean J Urol.
  • 2011 Jul;52(7):461-465.
PURPOSE: We evaluated the effectiveness of second-line maximum androgen blockade (MAB) with an alternative antiandrogen in patients who relapsed after initial MAB. MATERIALS AND METHODS: We retrospectively analyzed 47 patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adjuvant Effect of IV Clodronate on the Delay of Bone Metastasis in High-Risk Prostate Cancer Patients: A Prospective Study

Rodrigues , Hering FO, Meller A

  • KMID: 2167565
  • Cancer Res Treat.
  • 2011 Dec;43(4):231-235.
PURPOSE: High-risk prostate cancer patients undergoing treatment often experience biochemical recurrence. The use of bisphosphonates as an adjuvant treatment delays skeletal events, yet whether or not bisphosphonates also delay metastastic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nonmetastatic Castration-Resistant Prostate Cancer

Hong JH, Kim IY

After the introduction of prostate cancer screening with the prostate-specific antigen (PSA) test, we have witnessed a dramatic stage migration. As a result, an increasing number of patients are diagnosed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Androgen deprivation therapy is associated with decreased second primary lung cancer risk in the United States veterans with prostate cancer

Jung K, Park JC, Kang H, Brandes JC

OBJECTIVES: We investigated whether androgen deprivation therapy (ADT) in prostate cancer patients was associated with a decreased risk for second primary lung cancer in US veterans. METHODS: Prostate cancer diagnoses in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Significance of Prostate-specific Antigen Level Two Months after Maximal Androgen Blockade in Metastatic Prostate Cancer

Park BJ, Lee YG, Ahn HK

  • KMID: 2293544
  • Korean J Urol.
  • 2003 Sep;44(9):855-860.
PURPOSE: The aim of this study was to analyze the prognostic significance of pre- and post-treatment serum prostate-specific antigen (PSA) level, together with a variety of other clinicopathological parameters, in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypersexuality in Dementia

Cheon JS

  • KMID: 2186208
  • J Korean Geriatr Psychiatry.
  • 2003 Jun;7(1):76-82.
PURPOSE: Hypersexual behavior such as increased libido, change in sexual orientation or disinhibition had been reported in dementia. Mechanism and treatment measures were reviewed. METHOD: A medline search was undertaken...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Prostate Carcinoma Metastasized to Bilateral Breasts

Cho HJ, Lee ES, Park JS, Bae JY, Park SH

  • KMID: 1873046
  • Korean J Urol.
  • 2005 Jan;46(1):96-99.
Antiandrogens are generally used for the treatment of prostate cancer, with gynecomastia the most common adverse event seen during therapy. However, a breast mass in a man with a carcinoma...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary Androgen Deprivation Therapy for Prostate Cancer in Koreans: A Retrospective Multicenter Study

Seo WI, Kang PM, Kim TH, Moon KH, Chung JM, Lee DH, Kim IY, Min K, Chung J, Kim W, Kang DI

PURPOSE: To evaluate the characteristics of patients who received primary androgen deprivation therapy (PADT) for prostate cancer and the clinical efficacy of this treatment. MATERIALS AND METHODS: Two hundred forty patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Exponential Rise in Prostate-Specific Antigen (PSA) during Anti-Androgen Withdrawal Predicts PSA Flare after Docetaxel Chemotherapy in Patients with Castration-Resistant Prostate Cancer

Han KS, Hong SJ

PURPOSE: To investigate the relationship between rising patterns of prostate-specific antigen (PSA) before chemotherapy and PSA flare during the early phase of chemotherapy in patients with castration-resistant prostate cancer (CRPC). MATERIALS...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metabolic effects of androgen deprivation therapy

Choi SM, Kam SC

The therapeutic effects and side effects of androgen deprivation therapy (ADT), which is a main treatment method for metastatic prostate cancer, are well known, but the metabolic effects have only...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Influence of Androgen Deprivation Therapy on the Uptake of PSMA-Targeted Agents: Emerging Opportunities and Challenges

Bakht MK, Oh SW, Youn H, Cheon GJ, Kwak C, Kang KW

Prostate-specific membrane antigen (PSMA) is an attractive target for both diagnosis and therapy because of its high expression in the vast majority of prostate cancers. Development of small molecules for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medical Treatment of the Benign Prostatic Hyperplasia

Chang SG

The search for nonhormonal pharmacological agents capable of reducing out flow obstruction caused by benign prostatic hyperplasia (BPH) began in the 1970s when alpha adrenergic receptors were demonstrated within the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment

Ku JY, Lee JZ, Ha HK

PURPOSE: To investigate the efficacy of androgen deprivation treatment (ADT) between continuous and intermittent ADT. MATERIALS AND METHODS: Between January 2006 and May 2015, 603 patients were selected and divided into...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Unrecognized Kinetics of Serum Testosterone: Impact on Short-Term Androgen Deprivation Therapy for Prostate Cancer

Koo KC, Lee DH, Kim KH, Lee SH, Hong CH, Hong SJ, Chung BH

PURPOSE: To evaluate the kinetics of serum testosterone (T) recovery following short-term androgen deprivation therapy (ADT), as the understanding thereof is essential for the proper management of prostate cancer (PCa),...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of antiandrogens upon the morphological development of gubernaculum and the testicular descent in rats

Han SW, Lee HY, Yang WI, Choi SK

  • KMID: 2036828
  • Korean J Urol.
  • 1992 Apr;33(2):239-249.
We evaluated the effect of antiandrogens on both fetal and adult rats, noting especially the morphological changes in the gubernaculum and testicular descent. Two antiandrogens, flutamide and 5a-reductase inhibitor 4-methyl-4-aza-5-pregnane-3-one-20[s] carboxylate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer

Jung J, Lee C, Lee C, Kwon T, You D, Jeong IG, Hong JH, Ahn H, Kim CS

PURPOSE: To determine whether statin use delays the development of castration-resistant prostate cancer (CRPC) in patients with metastatic prostate cancer treated with androgen deprivation therapy (ADT). MATERIALS AND METHODS: A total...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr